Working Group on Ethics and COVID-19
WHO has established an international Working Group on Ethics and COVID-19 in order to develop advice on key ethical questions that Member States need to address. The expert group also advises WHO’s technical units regarding ethical aspects of their COVID-related work.

Background and mission

WHO has established an international Working Group on Ethics and COVID-19 in order to develop advice on key ethical questions that Member States need to address. The expert group also advises WHO’s technical units regarding ethical aspects of their COVID-related work. Since its formation in February 2020, the group has been engaged in the following activities: 

  • Advice on ethical considerations in COVID-19 research
  • Practical guidance on the application of ethical values central to COVID-19 research published in the journal “Public Health Ethics”
  • A policy brief on resource allocation and priority setting in COVID-19 care
  • Providing ethics input into the WHO's Clinical Management Guidelines and training 
  • Feedback provided on the Solidarity Trial protocol
  • Development of emergency standard operating procedures for human research committees to facilitate rapid review of protocols during the COVID-19 pandemic 
  • Advice on the criteria that must be satisfied for SARS-CoV-2 challenge studies to be ethically acceptable 
  • Considering other areas: Immunity certificates, MEURI (i.e., monitored emergency use of unregistered and experimental interventions) and the fair global allocation of vaccines, therapeutics, and diagnostics.